Geneformics, which grew out of Israel's Weizmann Institute, promises to boost the speed of moving data by tenfold and cut costs by 90 percent.
wiss genomic data management company BC Platforms seeks to add a clinical component to its existing software this year.
Hospitals in Morocco, Cameroon, and South Africa recently adopted its SOPHiA artificial intelligence offering, the firm's first crop of African customers.
Investigators intend to genotype the biorepository using Illumina arrays with the aim of identifying markers that can be used to inform treatment and prevention efforts.
The firm is counting on its experience integrating data from the oil and gas industry to change the way pharmaceutical data scientists work.
The combined product includes Edico’s Dragen bioinformatics processor integrated into a Dell server, as well as Dell EMC’s Isilon storage.
The platform features a more comprehensive list of pipelines, simplifies data movement and flow, and reduces analysis times.
TheSTARPlatform includes tools for analyzing genomic data from raw sequence through to variants calls as well as for compressing and storing data.
Consortium researchers will use the STARPlatform to manage whole exome and genome sequence from patients with three diffuse glioma subtypes.
Omicia will use the proceeds to accelerate product development, expand sales and marketing, and extend variations of its flagship Opal Clinical platform for NGS data analysis.
While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.
Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.
In Nature this week: paternal age associated with de novo mutations in children, and more.
Nature News writes that researchers are still wrangling over the role of the p-value.